© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
November 21, 2016
Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.
A Passionate Patient Advocate for Those With Cancer
The Gift of a Question in Cancer Care
Bringing Hope and Healing to Patients With Cancer
Discussing the Importance of Genetic Counseling in Women’s Cancer